Universal-Beteiligungs- und Servicegesellschaft
IOVA icon

Universal-Beteiligungs- und Servicegesellschaft’s Iovance Biotherapeutics IOVA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
74,730
+58,701
+366% +$223K ﹤0.01% 1923
2026
Q1 		$56.3K Sell
16,029
-17,328
-52% -$55.4K ﹤0.01% 2043
2025
Q4 		$91.1K Buy
33,357
+20,758
+165% +$48K ﹤0.01% 2024
2025
Q3 		$27.3K Buy
+12,599
New +$29.8K ﹤0.01% 2081
2025
Q2 		– Sell
-17,191
Closed -$57.2K – 2057
2025
Q1 		$57.2K Buy
+17,191
New +$88.7K ﹤0.01% 1969

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's IOVA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Iovance Biotherapeutics (IOVA) stake by 366% in Q2 2026, buying an estimated $223K and bringing the position to 74,730 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IOVA in Q1 2025 and has held it in 5 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 74,730 shares of Iovance Biotherapeutics worth $311K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 58,701 Iovance Biotherapeutics shares in Q2 2026, an estimated $223K.
  • Iovance Biotherapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1923 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Iovance Biotherapeutics in Q1 2025 and has held it in 5 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.